Skip to main content

Table 1 Patients’ baseline characteristics

From: The timing of administration of intravenous dexmedetomidine during lower limb surgery: a randomized controlled trial

 

Group A (n = 31)

Group B (n = 31)

P value

Sex (male/female)

22/9

15/16

0.12

Age

35.87 ± 11.22

38.74 ± 12.27

0.34

ASA (1/2)

26/5

26/5

0.70

Height

170.25 ± 6.14

167.22 ± 9.34

0.14

Weight

71.22 ± 10.02

67.62 ± 12.10

0.21

Infusion time of DEX (min)

86.93 ± 17.78

86.61 ± 12.99

0.94

Injection site (L3-4/L4-5)

13/18

15/16

0.80

Maximum sensory block level

T10 (8-10)

T10 (8.5-10)

0.16

  1. Values are expressed as number of patients, mean ± SD, and median (IQR). ASA American society of anesthesiologists classification, DEX dexmedetomidine, L lumbar, T thoracic dermatome, SD standard deviation, Injection site, intrathecal heavy bupivacaine injection site, IQR interquartile range
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us